Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Citi
Medtronic
Fuji
UBS
Novartis
Merck
Cerilliant
Boehringer Ingelheim
Cantor Fitzgerald

Generated: October 21, 2017

DrugPatentWatch Database Preview

Biofrontera Company Profile

« Back to Dashboard

What is the competitive landscape for BIOFRONTERA, and what generic alternatives to BIOFRONTERA drugs are available?

BIOFRONTERA has one approved drug.

There is one US patent protecting BIOFRONTERA drugs.

There are twelve patent family members on BIOFRONTERA drugs in eleven countries.

Summary for Applicant: Biofrontera

International Patents:12
US Patents:1
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Biofrontera
AMELUZ
aminolevulinic acid hydrochloride
GEL;TOPICAL208081-001May 10, 2016RXYesYes► Subscribe► Subscribe► Subscribe
Biofrontera
AMELUZ
aminolevulinic acid hydrochloride
GEL;TOPICAL208081-001May 10, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Biofrontera Drugs

Country Document Number Estimated Expiration
Australia758098► Subscribe
Australia1271000► Subscribe
Germany19852245► Subscribe
World Intellectual Property Organization (WIPO)0028971► Subscribe
Germany59908665► Subscribe
Austria260092► Subscribe
Portugal1128812► Subscribe
European Patent Office1128812► Subscribe
New Zealand511351► Subscribe
South Africa200104726► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
US Army
Citi
Johnson and Johnson
Queensland Health
Daiichi Sankyo
Medtronic
Moodys
Deloitte
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot